Drug Makers Restricting Nafamostat Supplies as Hopes Grow for Its Repurposing for COVID-19

Drug makers in Japan are moving to curb shipments for the acute pancreatitis drug nafamostat as its demand from medical institutions is soaring on the back of reports that it might be effective against the novel coronavirus disease (COVID-19). University...read more